CCL16 Antibody / LEC Antibody (RQ4655)

CCL16 Antibody Human Liver Cancer IHC. FFPE human liver cancer tissue was subjected to heat-induced epitope retrieval using pH8 EDTA buffer prior to staining with CCL16 antibody at 2 ug/ml. HRP-conjugated secondary antibody with DAB chromogen was used for visualization. CCL16 immunoreactivity is predominantly cytoplasmic within the liver carcinoma cells, while surrounding stromal and inflammatory cells exhibit comparatively weaker staining, supporting selective detection of CCL16 in the tumor tissue. This CCL16 Antibody, also called LEC Antibody, is suitable for studies of chemokine signaling, immune cell recruitment, inflammatory responses, liver biology, and the tumor microenvironment.

CCL16 Antibody Recombinant Protein WB. Western blot analysis detected recombinant human CCL16 protein loaded at two concentrations. Lanes: (1) 10 ng recombinant human CCL16 and (2) 5 ng recombinant human CCL16. A distinct band was observed at approximately 14 kDa in both lanes, demonstrating sensitive and specific detection of recombinant CCL16 protein. This CCL16 Antibody, also called LEC Antibody, is suitable for studies of chemokine signaling, immune cell recruitment, inflammatory responses, and cytokine biology.